Literature DB >> 8635579

Expression of rat chymotrypsinogen in yeast: a study on the structural and functional significance of the chymotrypsinogen propeptide.

I Venekei1, L Gráf, W J Rutter.   

Abstract

The role of the propeptide sequence and a disulfide bridge between sites 1 and 122 in chymotrypsin has been examined by comparing enzyme activities of wild-type and mutant enzymes. The kinetic constants of mutants devoid of the Cys1-Cys122 disulfide-linked propeptide show that this linkage is not important either for activity or substrate specificity. However this linkage appears to be the major factor in keeping the zymogen stable against non-specific activation. A comparison of zymogen stabilities showed that the trypsinogen propeptide is ten times more effective than the chymotrypsinogen propeptide in preventing non-specific zymogen activation during heterologous expression and secretion from yeast. This feature can also be transferred in trans to chymotrypsinogen; i.e. the chymotrypsin trypsin propeptide chimera forms a stable zymogen.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8635579     DOI: 10.1016/0014-5793(95)01483-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  A single mutation in the activation site of bovine trypsinogen enhances its accumulation in the fermentation broth of the yeast Pichia pastoris.

Authors:  José Hanquier; Yannick Sorlet; Dominique Desplancq; Laurence Baroche; Marc Ebtinger; Jean-François Lefèvre; Franc Pattus; Charles L Hershberger; Alain A Vertès
Journal:  Appl Environ Microbiol       Date:  2003-02       Impact factor: 4.792

2.  A fluorescence stopped-flow kinetic study of the conformational activation of alpha-chymotrypsin and several mutants.

Authors:  Gert Verheyden; Janka Matrai; Guido Volckaert; Yves Engelborghs
Journal:  Protein Sci       Date:  2004-09       Impact factor: 6.725

3.  Combinatorial enzyme design probes allostery and cooperativity in the trypsin fold.

Authors:  Michael J Page; Enrico Di Cera
Journal:  J Mol Biol       Date:  2010-04-24       Impact factor: 5.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.